99 Episodo

  1. Targeted therapy for BRAF-mutant pediatric glioma

    Publicado: 17/6/2022

  2. Early/evolving IDH wild-type glioblastoma

    Publicado: 20/5/2022

  3. PI3K signaling in IDH mutant gliomas

    Publicado: 6/5/2022

  4. Cell-free DNA from CSF in pediatric, adolescent and young adult patients

    Publicado: 22/4/2022

  5. Molecular determinants of neurocognitive deficits in glioma

    Publicado: 8/4/2022

  6. H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

    Publicado: 25/3/2022

  7. Clinical trial accrual for women and minorities in neuro-oncology

    Publicado: 11/3/2022

  8. The clinical utility of next generation sequencing for IDHwt glioblastoma

    Publicado: 11/2/2022

  9. Trabectedin for recurrent grade 2 or 3 meningiomas

    Publicado: 28/1/2022

  10. Glioblastoma cell heterogeneity and plasticity

    Publicado: 14/1/2022

  11. Moleculary integrated grading for meningioma

    Publicado: 24/12/2021

  12. BOLD fMRI in IDH mutant gliomas

    Publicado: 10/12/2021

  13. Glioblastoma subtypes and response to Dasatinib

    Publicado: 26/11/2021

  14. Resection for recurrent brain metastases

    Publicado: 12/11/2021

  15. Incidental Meningiomas

    Publicado: 29/10/2021

  16. Immunosuppression in IDH mutant gliomas

    Publicado: 15/10/2021

  17. Immunotherapy for melanoma brain metastases

    Publicado: 1/10/2021

  18. DNA methylation profiles within the CATNON trial

    Publicado: 17/9/2021

  19. 18F FET PET in childhood CNS tumors

    Publicado: 3/9/2021

  20. Checkpoint blockade in atypical meningiomas

    Publicado: 20/8/2021

4 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site